Inventor
E. DOUGLAS KRAMER
Inventor
US
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes50%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
PatentTitleYear
11,752,139Therapeutic combinations of orally administered irinotecan and a p-gp inhibitor for the treatment of cancer202311,497,750Methods of treating and/or preventing actinic keratosis202211,389,442Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancer2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to ATHENEX HK INNOVATIVE LTD (2)· patent assignee history
2022Patents assigned to ATHENEX INC (1)· patent assignee history
2022Patents assigned to ATNX SPV LLC (1)· patent assignee history
2022–2023Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ATHENEX HK INNOVATIVE LTD | 2 | 2022–2023 |
| ATHENEX INC | 1 | 2022 |
| ATNX SPV LLC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 3 | 2022–2023 |